"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about VALSARTAN
• Ask Community about VALSARTAN
• Read More Here
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

VALSARTAN Safety Questions, VALSARTAN Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about VALSARTAN. Our extensive database of VALSARTAN adverse events and VALSARTAN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about VALSARTAN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

VALSARTAN Safety Reports

Total VALSARTAN reports: 117.
VALSARTAN FDA safety alerts: No.
Reported deaths: 9    Reported hospitalizations: 79.
Take VALSARTAN Side Effects Survey or Share Your VALSARTAN Story. Read More Here.

Showing 1-75 of 117 Next >

Consumer or non-health professional from MEXICO reported VALSARTAN problem on Apr 17, 2007. Female patient, 73 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: chest pain, hypertension. VALSARTAN dosage: 2 X 160/25MG TABLET DAILY. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Consumer or non-health professional from SOUTH AFRICA on Apr 17, 2007. Female patient, 69 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, bone density decreased, diabetes mellitus. VALSARTAN dosage: VALS 80 / HCT 12.5 MG/DAY. During the same period patient was treated with GLUCOPHAGE, LIPITOR. Patient recovered.

Health Professional from SWITZERLAND reported VALSARTAN problem on Apr 23, 2007. Male patient, 44 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: adrenal adenoma, hyperaldosteronism, hypertension, retinopathy, ventricular hypertrophy. VALSARTAN dosage: unknown. During the same period patient was treated with CARVEDILOL, HYDROCHLOROTHIAZIDE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Consumer or non-health professional from MEXICO on Apr 23, 2007. Female patient was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: renal disorder. VALSARTAN dosage: unknown. During the same period patient was treated with PRIMPERAN, SIMVASTATIN, FUROSEMIDE, GLIBENCLAMIDE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported VALSARTAN problem on Apr 24, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: choroidal detachment, csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, ocular discomfort, optic nerve disorder. VALSARTAN dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Consumer or non-health professional from SOUTH AFRICA on Apr 26, 2007. Female patient, 69 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood pressure inadequately controlled, bone density decreased, diabetes mellitus. VALSARTAN dosage: VALS 80 / HCT 12.5 MG/DAY. During the same period patient was treated with GLUCOPHAGE, LIPITOR. Patient recovered.

Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA reported VALSARTAN problem on Apr 24, 2007. Female patient, 58 years of age, weighting 178.6 lb, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, discomfort, hyperglycaemia. VALSARTAN dosage: unknown. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA on Apr 30, 2007. Female patient, 83 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: fall. VALSARTAN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA reported VALSARTAN problem on May 02, 2007. Male patient, 54 years of age, weighting 172.0 lb, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, eye haemorrhage, gastritis, pancreatitis. VALSARTAN dosage: unknown. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Health Professional from SWITZERLAND on May 03, 2007. Male patient, 44 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: adrenal adenoma, blood aldosterone increased, hyperaldosteronism, hypertension, primary hyperaldosteronism, renin increased, retinopathy, ventricular hypertrophy. VALSARTAN dosage: unknown. During the same period patient was treated with CARVEDILOL, HYDROCHLOROTHIAZIDE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from SOUTH AFRICA reported VALSARTAN problem on May 03, 2007. Female patient, 59 years of age, was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: bronchitis, infection, oedema peripheral, pneumonia. VALSARTAN dosage: VALS 80 / HCT 12.5 MG/DAY. Patient recovered.

VALSARTAN problem was reported by a Physician from JAPAN on June 01, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: choroidal detachment, csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, ocular discomfort, optic nerve disorder. VALSARTAN dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported VALSARTAN problem on June 21, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: choroidal detachment, constipation, csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, insomnia. VALSARTAN dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Pharmacist from UNITED STATES on July 10, 2006. Male patient, 67 years of age, was diagnosed with proteinuria and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: blood potassium increased. VALSARTAN dosage: 160MG PO QD. During the same period patient was treated with ENALAPRIL MALEATE, ATENOLOL, CLONIDINE, METOLAZONE, GLIPIZIDE, SIMVASTATIN, CLONAZEPAM, TERAZOSIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported VALSARTAN problem on July 12, 2006. Female patient, 92 years of age, was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: cardiovascular insufficiency, nausea. VALSARTAN dosage: unknown. During the same period patient was treated with DIGOXIN, AROTINOLOL HYDROCHLORIDE, ISOSORBIDE, IFENPRODIL TARTRATE. Patient died.

VALSARTAN problem was reported by a Consumer or non-health professional from JAPAN on July 12, 2006. Female patient, 92 years of age, was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, cardiovascular insufficiency, nausea. VALSARTAN dosage: unknown. During the same period patient was treated with DIGOXIN, AROTINOLOL HYDROCHLORIDE, ISOSORBIDE DINITRATE, IFENPRODIL TARTRATE. Patient died.

Consumer or non-health professional from JAPAN reported VALSARTAN problem on Nov 02, 2005. Male patient, 50 years of age, weighting 149.9 lb, was diagnosed with hypertension, cerebral infarction, diabetes mellitus, oedema and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, blood creatinine increased, blood urine present, glomerulonephritis membranous, jaundice cholestatic, kidney enlargement, liver disorder, nephritis interstitial, oedema peripheral. VALSARTAN dosage: 80 MG, QD. During the same period patient was treated with BUFFERIN, PANALDINE, HUMACART, LASIX, CYCLOSPORINE. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Pharmacist from UNITED STATES on Sept 29, 2006. Male patient, 71 years of age, weighting 129.0 lb, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: hyponatraemia. VALSARTAN dosage: 80 MG DAILY PO. During the same period patient was treated with OMEPRAZOLE, SIMVASTATIN, VERAPAMIL, ASPIRIN. Patient recovered.

Physician from UNITED STATES reported VALSARTAN problem on Sept 18, 2006. Male patient, 79 years of age, was diagnosed with cardiovascular disorder, glucose tolerance impaired and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: bladder cancer, disease progression, urinary bladder excision. VALSARTAN dosage: unknown. During the same period patient was treated with NATEGLINIDE. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Consumer or non-health professional from SPAIN on Sept 29, 2006. Male patient, 60 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: renal failure. VALSARTAN dosage: unknown. Patient recovered.

Consumer or non-health professional from SPAIN reported VALSARTAN problem on Sept 29, 2006. Male patient, 60 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: azotaemia, coagulopathy, dialysis, dizziness, fluid intake reduced, haematuria, malaise, nausea, proteinuria. VALSARTAN dosage: unknown. During the same period patient was treated with DOXAZOSIN MESYLATE, LECARNIDIPINE. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Pharmacist from UNITED STATES on Oct 25, 2006. Male patient, 69 years of age, weighting 168.0 lb, was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea. VALSARTAN dosage: unknown. During the same period patient was treated with DIAZEPAM. Patient was hospitalized. Patient recovered.

Health Professional from LEBANON reported VALSARTAN problem on Oct 26, 2006. Female patient, 68 years of age, was diagnosed with headache, hyperuricaemia and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, biopsy, blood glucose increased, blood uric acid increased, coombs test positive, dyspnoea, eosinophil count increased, erythema, haemoglobin decreased. VALSARTAN dosage: 40 MG, QD. During the same period patient was treated with ACETAMINOPHEN, GLYBURIDE, AMLODIPINE, FUROSEMIDE, AMIODARONE, SIMVASTATIN, ALLOPURINOL. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Health Professional from UNITED KINGDOM on Oct 30, 2006. Female patient, 70 years of age, was diagnosed with tremor and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: dysphonia, dystonia, tremor. VALSARTAN dosage: 40 MG, QD. During the same period patient was treated with FLUVASTATIN, SINEMET CR, SINEMET CR, GLICLAZIDE, ACARBOSE, ROSIGLITAZONE, FLUOXETINE, ASPIRIN. Patient recovered.

Physician from UNITED STATES reported VALSARTAN problem on Oct 23, 2006. Male patient, 44 years of age, was diagnosed with hypertension, depression, hepatitis c and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: eye pruritus, retinal exudates, retinopathy, seasonal allergy, visual disturbance. VALSARTAN dosage: unknown. During the same period patient was treated with TEMAZEPAM, INTERFERON ALFA, CLONAZEPAM, HYDROXYZINE, RISPERIDONE, TRIHEXYPHENIDYL, INSULIN, METFORMIN. Patient recovered.

VALSARTAN problem was reported by a Physician from GERMANY on Nov 15, 2006. Male patient was diagnosed with hypertension, tachyarrhythmia, transient ischaemic attack and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: tachycardia. VALSARTAN dosage: unknown. During the same period patient was treated with METOPROLOL, DIGITOXIN, CLOPIDOGREL. Patient recovered.

Physician from BRAZIL reported VALSARTAN problem on June 30, 2004. Male patient, 74 years of age, weighting 151.0 lb, was diagnosed with diabetes mellitus non-insulin-dependent, hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, angiodysplasia, arteriovenous malformation, asthenia, chest pain, colonic polyp, concomitant disease progression, diverticulum intestinal, enterectomy. VALSARTAN dosage: 160 MG. During the same period patient was treated with NATEGLINIDE, AMLODIPINE. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Consumer or non-health professional from JAPAN on Nov 15, 2006. Female patient, 39 years of age, was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: caesarean section, oligohydramnios. VALSARTAN dosage: 80 MG/DAY. Patient recovered.

Physician from BRAZIL reported VALSARTAN problem on June 30, 2004. Male patient, 74 years of age, weighting 151.0 lb, was diagnosed with diabetes mellitus non-insulin-dependent, hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, angiodysplasia, arteriovenous malformation, asthenia, blood pressure increased, chest pain, colonic polyp, concomitant disease progression, diverticulum intestinal. VALSARTAN dosage: 160 MG. During the same period patient was treated with NATEGLINIDE, AMLODIPINE. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Physician from BRAZIL on June 30, 2004. Male patient, 74 years of age, weighting 151.0 lb, was diagnosed with diabetes mellitus non-insulin-dependent, hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, angiodysplasia, arteriovenous malformation, asthenia, chest pain, colonic polyp, concomitant disease progression, diverticulum intestinal, enterectomy. VALSARTAN dosage: 160 MG. During the same period patient was treated with NATEGLINIDE, AMLODIPINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported VALSARTAN problem on Nov 15, 2006. Female patient, 39 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: caesarean section, oligohydramnios. VALSARTAN dosage: 80 MG/DAY. Patient recovered.

VALSARTAN problem was reported by a Pharmacist from UNITED STATES on Dec 28, 2006. Female patient, 59 years of age, weighting 132.3 lb, was diagnosed with hypertension, hiatus hernia and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: chromaturia, decreased appetite, jaundice, nausea, ocular icterus, weight decreased. VALSARTAN dosage: unknown. During the same period patient was treated with ACIPHEX, HYDROCHLOROTHIAZIDE, DIGOXIN, ALLEGRA, VIT C, FOSAMAX, ALEVE. Patient was hospitalized. Patient recovered.

Physician from BRAZIL reported VALSARTAN problem on July 03, 2007. Male patient, 74 years of age, weighting 151.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, angiodysplasia, arteriovenous malformation, asthenia, chest pain, colonic polyp, concomitant disease progression, diverticulum intestinal, enterectomy. VALSARTAN dosage: 160 MG. During the same period patient was treated with NATEGLINIDE, AMLODIPINE. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Physician from JAPAN on June 29, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: choroidal detachment, constipation, csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, insomnia. VALSARTAN dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

Physician from BRAZIL reported VALSARTAN problem on July 13, 2007. Male patient, 74 years of age, weighting 151.0 lb, was diagnosed with cardiovascular disorder, type 2 diabetes mellitus, hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, angiodysplasia, arteriovenous malformation, asthenia, chest pain, colonic polyp, concomitant disease progression, diverticulum intestinal, enterectomy. VALSARTAN dosage: unknown. During the same period patient was treated with NATEGLINIDE, AMLODIPINE. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Physician from BRAZIL on July 11, 2007. Male patient, 74 years of age, weighting 151.0 lb, was diagnosed with cardiovascular disorder, type 2 diabetes mellitus, hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, angiodysplasia, arteriovenous malformation, asthenia, chest pain, colonic polyp, concomitant disease progression, diverticulum intestinal, enterectomy. VALSARTAN dosage: unknown. During the same period patient was treated with NATEGLINIDE, AMLODIPINE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported VALSARTAN problem on July 19, 2007. Male patient, 56 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. VALSARTAN dosage: 160MG EVERY DAY PO. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Pharmacist from UNITED STATES on July 23, 2007. Female patient, 83 years of age, was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: angioedema. VALSARTAN dosage: unknown. Patient recovered.

Consumer or non-health professional from FRANCE reported VALSARTAN problem on July 26, 2007. Male patient, 41 years of age, was diagnosed with hypertension, overweight, diabetes mellitus, dyslipidaemia and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: back pain, blood calcium increased, blood creatinine increased, blood phosphorus decreased, leukocytosis, pyrexia, red blood cell sedimentation rate increased, renal failure acute. VALSARTAN dosage: unknown. During the same period patient was treated with ACOMPLIA, ESOMEPRAZOLE MAGNESIUM, AVANDAMET, DIAMICRON, LIPANTHYL. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Physician from FRANCE on Aug 07, 2007. Female patient, 43 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: abortion induced. VALSARTAN dosage: unknown. Patient recovered.

Physician from JAPAN reported VALSARTAN problem on Aug 07, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: choroidal detachment, constipation, csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, insomnia. VALSARTAN dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.

VALSARTAN problem was reported by a Consumer or non-health professional from FRANCE on Aug 28, 2007. Male patient, 71 years of age, was diagnosed with hypertension, insomnia, asthma and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, antiphospholipid antibodies positive, coagulation factor viii level decreased, purpura. VALSARTAN dosage: unknown. During the same period patient was treated with RILMENIDINE, NOCTRAN, SERETIDE. Patient was hospitalized. Patient recovered.

Showing 1-75 of 117 Next >

Ask Our Patient Community about VALSARTAN
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed Pemoline Pentobarbital and carbromal Perflutren lipid microspheres Perindopril Phenergan (promethazine) Pimecrolimus Pioglitazone Placidyl (ethchlorvynol) Plan B (levonorgestrel) Pletal (cilostazol) Poractant alfa Posaconazole Pramlintide Acetate Precedex (dexmedetomidine) Pregabalin Prezista (darunavir) Prialt (ziconotide) Priftin (rifapentine) Prinivil (lisinopril) Procrit (epoetin alfa) ProHance (gadoteridol) Promethazine Propofol Prosom (estazolam) Protonix (pantoprazole) Protopic (tacrolimus) Provigil (modafinil) Prozac (fluoxetine) Prussian blue back to top	Q Quazepam Quetiapine Quinapril Quinupristin R Rabeprazole Radiogardase (prussian blue) Ramelteon Ramipril Ranexa (ranolazine) Ranibizumab Ranolazine Rapamune (sirolimus) Raptiva (efalizumab) Rasagiline Razadyne (galantamine) Rebetol (ribavirin) Reclast (zoledronic acid) Refludan (lepirudin recombinant) Relenza (zanamivir) Relpax (eletriptan) Remeron (mirtazapine) Renagel (sevelamer) Rescula (unoprostone isopropyl) Restoril (temazepam) Revatio (sildenafil) Revlimid (lenalidomide) Reyataz (atazanavir sulfate) Ribasphere (ribavarin ribasphere) Ribavarin ribasphere Rifapentine Rifaximin Risedronate Risperdal (risperidone) Risperidone Ritalin (methylphenidate) Ritonavir Rituxan Rituximab Rivastigmine tartrate Rizatriptan Rocephin (ceftriaxone) Rofecoxib Rosuvastatin Rozerem (ramelteon) back to top S Sacrosidase Salmeterol xinafoate Sanctura (trospium) Seconal (secobarbital) Secobarbital Selzentry Sensipar (cinacalcet) Serevent Diskus (salmeterol xinafoate) Seroquel (quetiapine) Sertaconazole Sertraline Serzone (nefazodone) Sevelamer Sildenafil citrate Sirolimus Simvastatin Sitagliptin phosphate Skelid (tiludronate) Sodium ferric gluconate complex Sodium phosphates Solage (mequinol; tretinoin) Soliris (eculizumab) Solifenacin succinate Somavert (pegvisomant) Sonata (zaleplon) Sorafenib Sotret (isotretinoin)